Table 3.
Safety and Adverse Events Reported in Included Randomized Controlled Trials
Intervention | ||||
---|---|---|---|---|
Study ID | ST36 injection | Control | Effect estimate RR (95%CI) | Adverse events |
Guo (2011)40 | 5/30 | 0/30 | 11.00 (0.64–190.53) | ST36 injection group: five participants had local pain but did not affect the treatment |
Shan (2009)43 | 1/34 | 3/33 | 0.32 (0.04–2.95) | ST36 injection group: one participant dropped out for treatment Control group: three participants dropped out |
Zhan (2009)51 | 1/40 | 0/40 | 3.00 (0.13–71.51) | ST36 injection group: one participant dropped out for treatment |
Wang (2011)45 | 0/30 | 0/30 | Not estimable | Adverse event was not found in both groups |
Total | 7/134 | 3/133 | 1.86 (0.20–17.24) |
CI, confidence intervals; RR, relative risk; ST36, Zusanli.